Search
Fenoprofen
go.drugbank.com/drugs/DB00573ApprovedAn anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.
α-Methylacetylfentanyl
go.drugbank.com/drugs/DB01532ExperimentalIllicitα-Methylacetylfentanyl is an analog of fentanyl with opioid analgesic properties. … anhydride for the production of chemical propionic anhydride in the synthesis.
Tozasertib
go.drugbank.com/drugs/DB19675InvestigationalTozasertib is under investigation in clinical trial NCT02532868 (A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002)). … The usage of the INN stem '-sertib' in the name indicates that Tozasertib is a serine/threonine kinase inhibitor.
Zelicapavir
go.drugbank.com/drugs/DB21662InvestigationalZelicapavir is under investigation in clinical trial NCT06601192 (A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults). … The usage of the INN stem '-capavir' in the name indicates that Zelicapavir is a viral capsid and nucleocapsid inhibitor.
Alnus incana subsp. rugosa pollen
go.drugbank.com/drugs/DB10453ApprovedAlnus incana subsp. rugosa pollen is mainly used in allergenic testing.
Xanthium strumarium var. canadense pollen
go.drugbank.com/drugs/DB10462ApprovedXanthium strumarium var. canadense pollen is mainly used in allergenic testing.
Populus deltoides subsp. monilifera pollen
go.drugbank.com/drugs/DB10465ApprovedPopulus deltoides subsp. monilifera pollen is mainly used in allergenic testing.
Populus balsamifera subsp. trichocarpa pollen
go.drugbank.com/drugs/DB10754ApprovedPopulus balsamifera subsp. trichocarpa pollen is mainly used in allergenic testing.
Lolium perenne subsp. multiflorum pollen
go.drugbank.com/drugs/DB10964ApprovedLolium perenne subsp. multiflorum pollen is mainly used in allergenic testing.
Ertumaxomab
go.drugbank.com/drugs/DB18923InvestigationalErtumaxomab is under investigation in clinical trial NCT00522457 (Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy).